RUA Life Sciences plc (FRA:AOHA)

RUA Life Sciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb 23, 2026	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	10	8	9	7	13	13
Market Cap Growth	-1.02%	-10.15%	36.15%	-49.74%	1.14%	-65.09%
Enterprise Value	7	5	6	6	11	8
Last Close Price	0.12	0.09	0.10	0.07	0.56	0.54
PE Ratio	-	-	7447.23	-	-	-
PS Ratio	1.88	1.57	1.81	2.55	5.24	6.69
PB Ratio	1.17	0.97	1.01	0.78	2.44	1.65
P/TBV Ratio	1.29	1.08	1.13	0.86	2.92	1.89
EV/Sales Ratio	1.34	1.02	1.21	2.53	4.30	3.99
EV/EBITDA Ratio	21.92	16.68	12.39	-	-	-
EV/FCF Ratio	-25.26	-	-	-	-	-
Debt / Equity Ratio	0.11	0.11	0.14	0.05	0.10	0.05
Debt / EBITDA Ratio	2.92	2.92	2.57	-	-	-
Net Debt / Equity Ratio	-0.34	-0.34	-0.34	-0.49	-0.21	-0.40
Net Debt / EBITDA Ratio	-9.03	-9.03	-6.33	2.25	0.52	1.28
Net Debt / FCF Ratio	10.41	10.41	9.03	2.56	0.63	0.80
Asset Turnover	-	-	0.47	0.32	0.33	0.18
Inventory Turnover	-	-	2.17	4.92	4.40	3.39
Quick Ratio	3.62	3.62	4.23	8.40	4.60	7.32
Current Ratio	4.64	4.64	4.91	9.01	5.20	8.23
Return on Equity (ROE)	-	-	0.01%	-24.27%	-35.55%	-27.40%
Return on Assets (ROA)	-	-	-0.14%	-17.51%	-21.69%	-16.54%
Return on Capital Employed (ROCE)	-2.20%	-2.20%	-0.20%	-25.40%	-43.90%	-33.10%
Earnings Yield	-1.74%	-2.08%	0.01%	-25.78%	-17.53%	-19.02%
FCF Yield	-2.82%	-3.38%	-3.77%	-24.76%	-13.96%	-29.96%
Buyback Yield / Dilution	-42.62%	-	-85.00%	-51.21%	-	-25.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.